2cureX (2CUREX.ST) Stock Price

2cureX Price

OMX·CLOSED
0.41
​
Market closed

Revenue at 2cureX has contracted by 21.0% per year over the past 9 years to 155,000.00 SEK. 2cureX's net margin stands at -20,979.4%, down from -66.2% several years earlier.

2cureX stock price

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

2cureX business model & stock analysis

2cureX AB develops anti-cancer treatments through research and development, focusing on diagnostic substances to optimize cancer patient care. Its key product, IndiTreat - CRC, enables healthcare professionals to test chemotherapies and experimental treatments using three-dimensional micro tumors created from patient tumor samples. The company also offers IndiTreat - OVA for ovarian cancer and IndiTreat - KDN for kidney cancer, forming its product pipeline. 2cureX AB operates through 2cureX A/S, targeting healthcare providers and oncology specialists who seek personalized treatment solutions for cancer patients. The company generates revenue by providing diagnostic services and product candidates to healthcare institutions. IndiTreat - CRC, IndiTreat - OVA, and IndiTreat - KDN are sold as diagnostic tools to hospitals and clinics specializing in cancer treatment. These products help medical teams select the most effective therapies for individual patients, reducing trial-and-error in cancer care. 2cureX AB's business model relies on the adoption of its diagnostic platform by oncology departments seeking precision medicine approaches. 2cureX AB's primary customers are healthcare professionals and institutions involved in cancer treatment, particularly those focused on colorectal, ovarian, and kidney cancers. The firm's diagnostic solutions are used to guide treatment decisions, with IndiTreat - CRC being the most advanced product in its pipeline. By offering tailored diagnostic services, 2cureX AB supports healthcare providers in delivering targeted therapies, aligning with the growing demand for personalized cancer care strategies.

Frequently asked questions about 2cureX

Converted at the current exchange rate, the 2cureX share trades at 0.04 EUR (0.41 SEK).

The 2cureX share (2CUREX.ST) is listed on 4 stock exchanges, including: Frankfurt (2QE.F), München (2QE.MU), Stockholm (2CUREX.ST).

The revenue cannot currently be calculated for 2cureX.

The profit cannot currently be calculated for 2cureX.

The P/E ratio cannot be calculated for 2cureX at the moment.

The P/S cannot be calculated for 2cureX currently.

The Eulerpool Quality Score for 2cureX is 2/10.

The ISIN of 2cureX is SE0010468124. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The WKN of 2cureX is A2H725. The WKN (Wertpapierkennnummer) is a six-digit German security identification number.

The ticker of 2cureX is 2CUREX.ST. The ticker symbol is used to trade 2cureX shares on the stock exchange.

Fair ValueTerminal
0.34 SEK
Over-/UndervaluationTerminal
Fairly valued
Sector
Industry
Health Care Equipment & Supplies
Number of shares
Employees
Revenue growth Ø5 years
EBIT growth Ø5 years
Net Income growth Ø5 years
Website 2curex.com
Country
Sweden
Currency
SEK
Initial public offering
Nov 24, 2017
ISIN
SE0010468124
Cusip
W9730E102
Market capitalization
10.31 M SEKMicro Cap
52-Week Range
PEG
—
P/E ratio
P/Ee
—
P/Se
—
EV/EBIT
—
P/B Ratio
2.02
ROE (Return on Equity)
ROA (Return on Assets)
ROCE (Return on Capital Employed)
ROIC (Return on Invested Capital)
-80.96 %
Last updated Oct 28, 2026, 9:52 PM

2cureX Peer Group

2cureX Ticker

FRANKFURT · 2QE.FMUNICH · 2QE.MUSTOCKHOLM · 2CUREX.STSTOCKHOLM · 2CUREX.ST

2cureX FIGI

2CUREX:SF · BBG00HYXTR292QE:GR · BBG00N7YV3S62QE:GF · BBG00N7YV3T52QE:GM · BBG00N7YV3Y92QE:GB · BBG00N7YV3Z82QE:GZ · BBG00NJ1XX432CUREEUR:EP · BBG00SMJLW802CUREEUR:EZ · BBG00SMJLWB62CUREEUR:XS · BBG00SMJLWD42CUREEUR:X2 · BBG00SMJLWF22CUREEUR:XH · BBG00SMJLWH02CUREEUR:XF · BBG00SMJLWK6

All fundamentals and in-depth analysis of 2cureX

Our stock analysis for 2cureX stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of 2cureX. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.